Clinical Trials Browser

Phase NA × Breast Neoplasms × disitamab vedotin × Clear all

NCT06015113 2023-08-29

Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis

Phase NA Not yet recruiting

Breast Neoplasms